Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group
Open Access
- 1 November 1999
- journal article
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 53 (11) , 702-709
- https://doi.org/10.1136/jech.53.11.702
Abstract
STUDY OBJECTIVE: To analyse the relation between coffee consumption and mutations in the K-ras gene in exocrine pancreatic cancer. DESIGN: Case-case study. Consumption of coffee among cases with the activating mutation in the K-ras gene was compared with that of cases without the mutation. SETTING AND PATIENTS: All cases of pancreatic cancer newly diagnosed at five hospitals in Spain during three years were included in the PANKRAS II Study (n = 185, of whom 121 whose tissue was available for molecular analysis are the object of the present report). Over 88% were personally interviewed in hospital. DNA was amplified from paraffin wax embedded tissues, and mutations in codon 12 of K-ras were detected by the artificial RFLP technique. MAIN RESULTS: Mutations were found in tumours from 94 of 121 patients (77.7%). Mutations were more common among regular coffee drinkers than among non-regular coffee drinkers (82.0% v 55.6%, p = 0.018, n = 107). The odds ratio adjusted by age, sex, smoking and alcohol drinking was 5.41 (95% CI 1.64, 17.78). The weekly intake of coffee was significantly higher among patients with a mutated tumour (mean of 14.5 cups/week v 8.8 among patients with a wild type tumour, p < 0.05). With respect to non-regular coffee drinkers, the odds ratio of a mutated tumour adjusted by age, sex, smoking and alcohol drinking was 3.26 for drinkers of 2-7 cups/week, 5.77 for drinkers of 8-14 cups/week and 9.99 for drinkers of > or = 15 cups/week (p < 0.01, test for trend). CONCLUSIONS: Pancreatic cancer cases without activating mutations in the K-ras gene had drank significantly less coffee than cases with a mutation, with a significant dose response relation: the less they drank, the less likely their tumours were to harbour a mutation. In exocrine pancreatic cancer the K-ras gene may be activated less often among non-regular coffee drinkers than among regular drinkers. Caffeine, other coffee compounds or other factors with which coffee drinking is associated may modulate K-ras activation.Keywords
This publication has 47 references indexed in Scilit:
- Learning from Case Reports: Diagnostic Issues in an Epidemiologic Study of Pancreatic CancerJournal of Clinical Epidemiology, 1998
- Effects of lifestyle and genetic polymorphisms on consumption of coffee or black tea and urinary caffeine levelsBiomarkers, 1998
- Chromosome changes caused by alterations of p53 expressionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996
- Comet assay studies indicate that caffeine-mediated increase in radiation risk of embryos is due to inhibition of DNA repairMutagenesis, 1996
- Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Coffee and Cancer of the PancreasPancreas, 1995
- Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cellsCarcinogenesis: Integrative Cancer Research, 1995
- Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancerInternational Journal of Cancer, 1994
- Validity of Self‐Reports of Caffeine UseThe Journal of Clinical Pharmacology, 1991
- Consumption of methylxanthine-containing beverages and risk of pancreatic cancerCancer Letters, 1990